The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

A groundbreaking advancement by a team of scientists in Australia—led by Indian-origin researchers—could dramatically change ...

A team of researchers has discovered that a protein called cypin plays a powerful role in helping brain cells connect and ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

A drug used for Parkinson's disease has been shown to be effective in reducing the symptoms of difficult to treat depression, ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

A team of neuroscientists in Australia has found that restoring copper levels in the brain dramatically reduced Parkinson-like damage in mice. The approach restored a protein’s function, and the same ...

Most Parkinson's symptoms stem from the loss or dysfunction of dopamine-producing neurons in a brain region involved in fine ...

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...

When 64-year-old MBK Nair first noticed a subtle tremor in his right hand in 2020, he brushed it off as fatigue or muscle weakness, assuming that could be a sig ...